BENAZEPRIL DIN 02273918
Health Canada record
| Active ingredient(s) | BENAZEPRIL HYDROCHLORIDE 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C09AA07 BENAZEPRIL |
| Original market date | 24-Mar-2006 |
| Current status date | 25-Jun-2012 |
| Source | Health Canada DPD |
Establishment licence of the holder
AA Pharma Inc. — licence 101851, currently licensed, last inspection rating C (2023-05-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BENAZEPRIL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02290332 | BENAZEPRIL | AA PHARMA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Marketed |
| 02290340 | BENAZEPRIL | AA PHARMA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 10 MG | Marketed |
| 02542102 | CARDALIS | CEVA ANIMAL HEALTH INC | Tablet (Chewable) | BENAZEPRIL HYDROCHLORIDE 2.5 MG; SPIRONOLACTONE 20 MG | Marketed |
| 02542099 | CARDALIS | CEVA ANIMAL HEALTH INC | Tablet (Chewable) | BENAZEPRIL HYDROCHLORIDE 10 MG; SPIRONOLACTONE 80 MG | Approved |
| 02542080 | CARDALIS | CEVA ANIMAL HEALTH INC | Tablet (Chewable) | BENAZEPRIL HYDROCHLORIDE 5 MG; SPIRONOLACTONE 40 MG | Marketed |
| 02305232 | FORTEKOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | BENAZEPRIL HYDROCHLORIDE 2.5 MG | Marketed |
| 02220555 | FORTEKOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Marketed |
| 02220563 | FORTEKOR FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Marketed |
| 00885843 | LOTENSIN 10MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 00885851 | LOTENSIN 20MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 00885835 | LOTENSIN 5MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 02231551 | PMS-BENAZEPRIL | PHARMASCIENCE INC | Tablet | BENAZEPRIL HYDROCHLORIDE 20 MG | Cancelled Pre Market |
| 02231550 | PMS-BENAZEPRIL | PHARMASCIENCE INC | Tablet | BENAZEPRIL HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02231548 | PMS-BENAZEPRIL | PHARMASCIENCE INC | Tablet | BENAZEPRIL HYDROCHLORIDE 5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11433 | 2010-05-27 | Abbreviated New Drug Submission (ANDS) | Manufacturer and product name change |
| 7629 | 2005-11-28 | Abbreviated New Drug Submission (ANDS) |
International API supply for BENAZEPRIL HYDROCHLORIDE
7 valid EDQM Certificates of Suitability from 7 holders. 14 active FDA Drug Master Files.
Request a quote for BENAZEPRIL